Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
oleh: Rosario Pivonello, Irina Bancos, Richard A. Feelders, Atil Y. Kargi, Janice M. Kerr, Murray B. Gordon, Cary N. Mariash, Massimo Terzolo, Noel Ellison, Andreas G. Moraitis
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2022-04-01 |
Deskripsi
Subjek
clinical trial; cortisol; Cushing syndrome; glucocorticoid; hypercortisolism; hyperglycemia